Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Anders

Showing results (141-150 of 271) with videos related to

Pageof 28
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2020
Effect of Dexrazoxane on Left Ventricular Systolic Function and Treatment Outcomes in Patients With Acute Myeloid Leukemia: A Report From the Children's Oncology GroupKelly D Getz, Lillian Sung, Todd A Alonzo, et al.
Pediatric Blood & Cancer|April 11, 2007
Initial testing (stage 1) of the proteasome inhibitor bortezomib by the pediatric preclinical testing programPeter J Houghton, Christopher L Morton, E Anders Kolb, et al.
Pediatric Blood & Cancer|February 23, 2008
Initial testing (stage 1) of sunitinib by the pediatric preclinical testing programJohn M Maris, Joshua Courtright, Peter J Houghton, et al.
Pediatric Blood & Cancer|March 27, 2015
Initial testing (stage 1) of the tubulin binding agent nanoparticle albumin-bound (nab) paclitaxel (Abraxane(®)) by the Pediatric Preclinical Testing Program (PPTP)Peter J Houghton, Raushan T Kurmasheva, E Anders Kolb, et al.
Pediatric Blood & Cancer|June 26, 2009
Initial testing (stage 1) of the kinesin spindle protein inhibitor ispinesib by the pediatric preclinical testing programHernan Carol, Richard Lock, Peter J Houghton, et al.
Pediatric Blood & Cancer|February 9, 2008
Stage 1 testing and pharmacodynamic evaluation of the HSP90 inhibitor alvespimycin (17-DMAG, KOS-1022) by the pediatric preclinical testing programMalcolm A Smith, Christopher L Morton, Doris A Phelps, et al.
Pediatric Blood & Cancer|July 20, 2007
Initial testing (stage 1) of the mTOR inhibitor rapamycin by the pediatric preclinical testing programPeter J Houghton, Christopher L Morton, E Anders Kolb, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 25, 2019
A Phase 2 Trial of KIR-Mismatched Unrelated Donor Transplantation Using in Vivo T Cell Depletion with Antithymocyte Globulin in Acute Myelogenous Leukemia: Children's Oncology Group AAML05P1 StudyStella M Davies, Robert Iannone, Todd A Alonzo, et al.
Pediatric Blood & Cancer|March 2, 2011
Initial testing (stage 1) of the polyamine analog PG11047 by the pediatric preclinical testing programMalcolm A Smith, John M Maris, Richard Lock, et al.
Pediatric Blood & Cancer|February 9, 2008
Initial testing (stage 1) of a monoclonal antibody (SCH 717454) against the IGF-1 receptor by the pediatric preclinical testing programE Anders Kolb, Richard Gorlick, Peter J Houghton, et al.
Pageof 28

Showing results (141-150 of 271) with videos related to

Sort By:
Pageof 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2020
Effect of Dexrazoxane on Left Ventricular Systolic Function and Treatment Outcomes in Patients With Acute Myeloid Leukemia: A Report From the Children's Oncology GroupKelly D Getz, Lillian Sung, Todd A Alonzo, et al.
Pediatric Blood & Cancer|April 11, 2007
Initial testing (stage 1) of the proteasome inhibitor bortezomib by the pediatric preclinical testing programPeter J Houghton, Christopher L Morton, E Anders Kolb, et al.
Pediatric Blood & Cancer|February 23, 2008
Initial testing (stage 1) of sunitinib by the pediatric preclinical testing programJohn M Maris, Joshua Courtright, Peter J Houghton, et al.
Pediatric Blood & Cancer|March 27, 2015
Initial testing (stage 1) of the tubulin binding agent nanoparticle albumin-bound (nab) paclitaxel (Abraxane(®)) by the Pediatric Preclinical Testing Program (PPTP)Peter J Houghton, Raushan T Kurmasheva, E Anders Kolb, et al.
Pediatric Blood & Cancer|June 26, 2009
Initial testing (stage 1) of the kinesin spindle protein inhibitor ispinesib by the pediatric preclinical testing programHernan Carol, Richard Lock, Peter J Houghton, et al.
Pediatric Blood & Cancer|February 9, 2008
Stage 1 testing and pharmacodynamic evaluation of the HSP90 inhibitor alvespimycin (17-DMAG, KOS-1022) by the pediatric preclinical testing programMalcolm A Smith, Christopher L Morton, Doris A Phelps, et al.
Pediatric Blood & Cancer|July 20, 2007
Initial testing (stage 1) of the mTOR inhibitor rapamycin by the pediatric preclinical testing programPeter J Houghton, Christopher L Morton, E Anders Kolb, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 25, 2019
A Phase 2 Trial of KIR-Mismatched Unrelated Donor Transplantation Using in Vivo T Cell Depletion with Antithymocyte Globulin in Acute Myelogenous Leukemia: Children's Oncology Group AAML05P1 StudyStella M Davies, Robert Iannone, Todd A Alonzo, et al.
Pediatric Blood & Cancer|March 2, 2011
Initial testing (stage 1) of the polyamine analog PG11047 by the pediatric preclinical testing programMalcolm A Smith, John M Maris, Richard Lock, et al.
Pediatric Blood & Cancer|February 9, 2008
Initial testing (stage 1) of a monoclonal antibody (SCH 717454) against the IGF-1 receptor by the pediatric preclinical testing programE Anders Kolb, Richard Gorlick, Peter J Houghton, et al.
Pageof 28